Evaluate Safety and Efficacy of Duloxetine in Predominant Stress Urinary Incontinence
Phase 3
Completed
- Conditions
- Urinary Incontinence, Stress
- Registration Number
- NCT00190996
- Lead Sponsor
- Eli Lilly and Company
- Brief Summary
The purposes of this study are to determine whether duloxetine can help subjects with stress urinary incontinence and to see whether the effects of duloxetine can be maintained.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 2765
Inclusion Criteria
- Female diagnosed with stress urinary incontinence
Exclusion Criteria
- Currently taking a monoamine oxidase inhibitor
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Assess the efficacy of Duloxetine compared with placebo in women with predominant stress urinary incontinence as measured by a reduction in incontinent episode frequency.
- Secondary Outcome Measures
Name Time Method Evaluate the maintenance of effect on IEF in long-term use Kings Health Questionnaire Patient Global Impression of Improvement Questionnaire Safety effects
Trial Locations
- Locations (1)
For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon-Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
🇬🇧Surrey, United Kingdom